The current status of aromatase inhibitors in the management of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The current status of aromatase inhibitors in the management of breast cancer

Published:2003-08 Issue:4 Volume:83 Page:973-994
ISSN:0039-6109
Container-title:Surgical Clinics of North America
language:en
Short-container-title:Surgical Clinics of North America

Author:

Baum Michael,Buzdar Aman

Publisher

Elsevier BV

Subject

Surgery

Reference57 articles.

1. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years;Peto;Lancet,2000

2. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases;Beatson;Lancet,1896

3. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal woman with early breast cancer: first results of the ATAC randomized trial. The ATAC Trialists Group;The ATAC Trialists Group;Lancet,2002

4. Inhibition of human mammary and prostatic cancer by adrenalectomy;Huggins;Cancer Res,1952

5. Influence of synthetic estrogens upon advanced malignant disease;Haddow;BMJ,1944

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Antiproliferative Activity of Novel Flavone Derivatives;Letters in Drug Design & Discovery;2023-10

2. Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates;Pathobiology;2022

3. Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis;Journal of Korean Medical Science;2020

4. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer;European Journal of Medicinal Chemistry;2015-09

5. Early and late tamoxifen resistance in breast cancer;Archives of Biological Sciences;2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3